BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32846898)

  • 1. Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells.
    Wongwan T; Chatsudthipong V; Soodvilai S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32846898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of liver X receptor inhibits OCT2-mediated organic cation transport in renal proximal tubular cells.
    Wongwan T; Kittayaruksakul S; Asavapanumas N; Chatsudthipong V; Soodvilai S
    Pflugers Arch; 2017 Nov; 469(11):1471-1481. PubMed ID: 28741179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
    Müller F; König J; Hoier E; Mandery K; Fromm MF
    Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.
    van der Velden M; Bilos A; van den Heuvel JJMW; Rijpma SR; Hurkmans EGE; Sauerwein RW; Russel FGM; Koenderink JB
    Malar J; 2017 Oct; 16(1):422. PubMed ID: 29061131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The multidrug transporter MATE1 sequesters OCs within an intracellular compartment that has no influence on OC secretion in renal proximal tubules.
    Martínez-Guerrero LJ; Evans KK; Dantzler WH; Wright SH
    Am J Physiol Renal Physiol; 2016 Jan; 310(1):F57-67. PubMed ID: 26538438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine.
    Müller F; Weitz D; Derdau V; Sandvoss M; Mertsch K; König J; Fromm MF
    Mol Pharm; 2017 Sep; 14(9):2991-2998. PubMed ID: 28708400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms.
    Guo C; LaCerte C; Edwards JE; Brouwer KR; Brouwer KLR
    J Pharmacol Exp Ther; 2018 May; 365(2):413-421. PubMed ID: 29487110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport Turnover Rates for Human OCT2 and MATE1 Expressed in Chinese Hamster Ovary Cells.
    Zhang X; Wright SH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations.
    König J; Zolk O; Singer K; Hoffmann C; Fromm MF
    Br J Pharmacol; 2011 Jun; 163(3):546-55. PubMed ID: 20883471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium.
    Deutsch B; Neumeister C; Schwantes U; Fromm MF; König J
    Mol Pharm; 2019 Feb; 16(2):510-517. PubMed ID: 30656943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K; Kim YM; Kim YW; Kim SG
    Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Aspects of Drug-Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K).
    Saad AAA; Zhang F; Mohammed EAH; Wu X
    Biol Pharm Bull; 2022; 45(4):382-393. PubMed ID: 35370262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germacrone Reduces Cisplatin-Induced Toxicity of Renal Proximal Tubular Cells via Inhibition of Organic Cation Transporter.
    Soodvilai S; Meetam P; Siangjong L; Chokchaisiri R; Suksamrarn A; Soodvilai S
    Biol Pharm Bull; 2020; 43(11):1693-1698. PubMed ID: 33132314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2K.
    Xiao G; Rowbottom C; Boiselle C; Gan LS
    Pharm Res; 2018 Jun; 35(8):159. PubMed ID: 29915999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide.
    Doki K; Apáti S; Sakata T; Homma M
    Biol Pharm Bull; 2019; 42(7):1226-1229. PubMed ID: 31257298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition.
    Müller F; Weitz D; Mertsch K; König J; Fromm MF
    Mol Pharm; 2018 Aug; 15(8):3425-3433. PubMed ID: 29975542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
    Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.
    Belzer M; Morales M; Jagadish B; Mash EA; Wright SH
    J Pharmacol Exp Ther; 2013 Aug; 346(2):300-10. PubMed ID: 23709117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.